About QPS Bioserve India Private Limited
Data last updated:
QPS Bioserve India Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Xdd Acquisition B.V. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 20 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85110TG2004PTC044908. Its GSTIN is 36AACCB5221D1Z9 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹4.25 Cr and a paid-up capital of ₹3.88 Cr. It was formerly known as Bioserve Laboratories Private Limited and Bioserve Clinical Research Private Limited. It is led by directors including Benjamin Mingta Chien and Chang Jen Yen.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 2nd Floor Plot No. 47 Ida Balanagar Medchal – Malkajgiri (Dist), Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2025, the company reported a revenue of ₹78.02 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹23.1 Cr (net margin 29.6%) and EBITDA of ₹34.11 Cr (EBITDA margin 43.7%). Revenue has grown at a compounded annual rate (CAGR) of 16% over five years.
The company has about 167 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Qps Bioserve and QPS. As per MCA filings, the company has open charges of ₹14.16 Lakh and satisfied charges of ₹16.53 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹1.81 Cr; the latest was in July 2017. Its 6 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 2 larger and 4 smaller; the largest is Pharmaceutical Research Associates India Private Limited with revenue of ₹111.96 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website qps.com.
Company details
Name history
QPS Bioserve India has undergone 2 name changes throughout its history. The company was previously known as Bioserve Laboratories Private Limited, and Bioserve Clinical Research Private Limited. The current legal name is Qps Bioserve India Private Limited.
| Company Name | Status |
|---|---|
| QPS Bioserve India Private Limited | Current |
| Bioserve Laboratories Private Limited | Previous |
| Bioserve Clinical Research Private Limited | Previous |
CIN history
QPS Bioserve India has one previous CIN (Corporate Identification Number): U85110AP2004PTC044908. The current CIN is U85110TG2004PTC044908, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110TG2004PTC044908 | Current |
| U85110AP2004PTC044908 | Previous |
Contact details
QPS Bioserve India Private Limited's registered office is in Hyderabad, Telangana. Its website is qps.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Apps
- Registered Address2nd Floor Plot No. 47 Ida Balanagar Medchal – Malkajgiri (Dist), Hyderabad, Telangana, India – 500037
- IndustryPharma, Pharma Contract R&D
To see the full contact details of QPS Bioserve India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
QPS Bioserve India operates two associated brands: Qps Bioserve and QPS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers end-to-end contract research services focused on the generic pharmaceutical industry. | qpsbioserve.com | |
| Contract research organisation offering drug discovery, preclinical and clinical development services | qps.com |
Business activity
The main business activity of QPS Bioserve India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of QPS Bioserve India Private Limited, buy the company report.
Financials of QPS Bioserve India Private Limited
FY 2024 filings availableQPS Bioserve India Private Limited reported revenue of ₹78.02 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 11% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43.7% | ||||
| Net Profit Margin | 29.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of QPS Bioserve India Private Limited, buy the company report.
Board of directors of QPS Bioserve India Private Limited
QPS Bioserve India has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Benjamin Mingta Chien | Nominee Director | 11 Mar 2011 | 15 Years 7 Months | Current |
| Chang Jen Yen | Nominee Director | 11 Mar 2011 | 15 Years 7 Months | Current |
| Kumar Ramu | Nominee Director | 11 Mar 2011 | 15 Years 7 Months | Current |
Peer comparison
QPS Bioserve India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmaceutical Research Associates India Private Limited | ₹111.96 Cr (FY 2025) | -9.0% | Bangalore, Karnataka, India | |||
| Eurofins Advinus Biopharma Services India Private Limited | ₹82.9 Cr (FY 2025) | -40.0% | Bengaluru, Karnataka, India | |||
| QPS Bioserve India Private Limitedthis company | ₹78.02 Cr (FY 2025) | ₹23.1 Cr | 29.6% | 11.0% | 167 | Hyderabad, Telangana, India |
| V-Ensure Pharma Technologies Private Limited | ₹77.73 Cr (FY 2025) | 10.0% | Navi Mumbai, Maharashtra, India | |||
| Difgen Pharmaceuticals Private Limited | ₹76.63 Cr (FY 2025) | 84.0% | Hyderabad, Telangana, India | |||
| Ecron Acunova Limited | ₹75.29 Cr (FY 2025) | 20.0% | Bangalore, Karnataka, India | |||
| Sun Pharma Advanced Research Company Limited | ₹73.56 Cr (FY 2025) | -30.0% | Manjusar, Gujarat, India |
To see the full peer comparison of QPS Bioserve India Private Limited, buy the company report.
Auditor
QPS Bioserve India Private Limited is audited by Suresh Surana & Associates LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Suresh Surana & Associates LLP | FY 2022 | 121750W/W-100010 |
Shareholding
The shareholding of QPS Bioserve India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of QPS Bioserve India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2005 | 90260207 | Icici Bank Limited | ₹14.16 Lakh | Open | |
| 20 Jan 2011 | 10264879 | Ge Capital Services India | ₹92.09 Lakh | Satisfied | |
| 08 Dec 2010 | 10252665 | Ge Capital Services India | ₹1.96 Cr | Satisfied | |
| 28 Jun 2010 | 10228508 | Ge Capital Services India | ₹1.23 Cr | Satisfied | |
| 28 Mar 2007 | 10049349 | Ge Capital Services India | ₹1.45 Cr | Satisfied |
To see the full charge records of QPS Bioserve India Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
QPS Bioserve India Private Limited has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹1.81 Cr; the latest was in July 2017.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2017 | Secondary share transfer | Undisclosed | Buyer: QPS Holding LLC, an individual Seller: 4 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2014 | Acquisition | Undisclosed | Buyer: Intertek India Private Limited Seller: QPS Bioserve India Private Limited |
| May 2012 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
To see the full deal history of QPS Bioserve India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
QPS Bioserve India Private Limited has 1 court case on record: 1 filed by QPS Bioserve India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against The Union of India, and 4 others | Disposed |
To see the full case history of QPS Bioserve India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for QPS Bioserve India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
QPS Bioserve India Private Limited has a workforce of 167 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
QPS Bioserve India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCB5221D1Z9 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of QPS Bioserve India Private Limited, buy the company report.
Recent activity
QPS Bioserve India Private Limited has 7 board changes on record since 2010: 3 appointments and 4 cessations. The latest: Sunil Kondapally Chandra ceased to be Director on 30 Mar 2017.
13 earlier events are in the company report.
News
Frequently asked questions
QPS Bioserve India is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 20 December 2004 (22+ years old) and is registered under CIN U85110TG2004PTC044908.
QPS Bioserve India has 3 current directors:
- Benjamin Mingta Chien - Nominee Director
- Chang Jen Yen - Nominee Director
- Kumar Ramu - Nominee Director
The latest financial statements of QPS Bioserve India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of QPS Bioserve India is 36AACCB5221D1Z9, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of QPS Bioserve India is U85110TG2004PTC044908. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
QPS Bioserve India has 1 court case on record: 1 filed by the company.
QPS Bioserve India was incorporated on 20 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
QPS Bioserve India has 9 deals on record (6 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹1.81 Cr; the latest was in July 2017.
The peers of QPS Bioserve India by revenue are Pharmaceutical Research Associates India Private Limited, Eurofins Advinus Biopharma Services India Private Limited, V-Ensure Pharma Technologies Private Limited, Difgen Pharmaceuticals Private Limited, Ecron Acunova Limited and 1 more, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Sunil Kondapally Chandra ceased to be Director on 30 Mar 2017. Sura Surendranath Reddy ceased to be Director on 30 Mar 2017. Benjamin Mingta Chien was appointed as Nominee Director on 11 Mar 2011. QPS Bioserve India has 7 board changes on record in total.
QPS Bioserve India can be reached through the website qps.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
